Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
Pneumatosis Intestinalis in a Patient with Acute Promyelocytic Leukemia.

Case reports in hematology

Mangaonkar A, Mansour J, Keen R, Kukkadapu T, Chintalapally R, Kota V.
PMID: 26635981
Case Rep Hematol. 2015;2015:576042. doi: 10.1155/2015/576042. Epub 2015 Oct 08.

Pneumatosis Intestinalis is a rare condition characterized by the presence of gas within the intestinal wall. We describe a case of a 33-year-old woman with acute promyelocytic leukemia who developed nausea and nonbloody diarrhea. CT showed intramural air in...

Cite
Mangaonkar A, Mansour J, Keen R, et al. Pneumatosis Intestinalis in a Patient with Acute Promyelocytic Leukemia. Case Rep Hematol. 2015;2015:576042doi: 10.1155/2015/576042.
Mangaonkar, A., Mansour, J., Keen, R., Kukkadapu, T., Chintalapally, R., & Kota, V. (2015). Pneumatosis Intestinalis in a Patient with Acute Promyelocytic Leukemia. Case reports in hematology, 2015576042. https://doi.org/10.1155/2015/576042
Mangaonkar, Abhishek, et al. "Pneumatosis Intestinalis in a Patient with Acute Promyelocytic Leukemia." Case reports in hematology vol. 2015 (2015): 576042. doi: https://doi.org/10.1155/2015/576042
Mangaonkar A, Mansour J, Keen R, Kukkadapu T, Chintalapally R, Kota V. Pneumatosis Intestinalis in a Patient with Acute Promyelocytic Leukemia. Case Rep Hematol. 2015;2015:576042. doi: 10.1155/2015/576042. Epub 2015 Oct 08. PMID: 26635981; PMCID: PMC4618106.
Copy Download .nbib Format: NLM
Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.

Hematology reports

Jillella AP, Arellano ML, Heffner LT, Gaddh M, Langston AA, Khoury HJ, Mangoankar A, Kota VK.
PMID: 29071052
Hematol Rep. 2017 Sep 26;9(3):7083. doi: 10.4081/hr.2017.7083. eCollection 2017 Sep 26.

No abstract available.

Cite
Jillella AP, Arellano ML, Heffner LT, et al. Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematol Rep. 2017;9(3):7083doi: 10.4081/hr.2017.7083.
Jillella, A. P., Arellano, M. L., Heffner, L. T., Gaddh, M., Langston, A. A., Khoury, H. J., Mangoankar, A., & Kota, V. K. (2017). Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematology reports, 9(3), 7083. https://doi.org/10.4081/hr.2017.7083
Jillella, Anand P, et al. "Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation." Hematology reports vol. 9,3 (2017): 7083. doi: https://doi.org/10.4081/hr.2017.7083
Jillella AP, Arellano ML, Heffner LT, Gaddh M, Langston AA, Khoury HJ, Mangoankar A, Kota VK. Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematol Rep. 2017 Sep 26;9(3):7083. doi: 10.4081/hr.2017.7083. eCollection 2017 Sep 26. PMID: 29071052; PMCID: PMC5641824.
Copy Download .nbib Format: NLM
Nonmonotonic diffusion rates in an atom-optics Lévy kicked rotor.

Physical review. E

Paul S, Sarkar S, Vishwakarma C, Mangaonkar J, Santhanam MS, Rapol U.
PMID: 31962514
Phys Rev E. 2019 Dec;100(6):060201. doi: 10.1103/PhysRevE.100.060201.

The dynamics of chaotic Hamiltonian systems such as the kicked rotor continues to guide our understanding of transport and localization processes. The localized states of the quantum kicked rotor decay due to decoherence effects if subjected to noise. The...

Cite
Paul S, Sarkar S, Vishwakarma C, et al. Nonmonotonic diffusion rates in an atom-optics Lévy kicked rotor. Phys Rev E. 2019;100(6):060201doi: 10.1103/PhysRevE.100.060201.
Paul, S., Sarkar, S., Vishwakarma, C., Mangaonkar, J., Santhanam, M. S., & Rapol, U. (2019). Nonmonotonic diffusion rates in an atom-optics Lévy kicked rotor. Physical review. E, 100(6), 060201. https://doi.org/10.1103/PhysRevE.100.060201
Paul, Sanku, et al. "Nonmonotonic diffusion rates in an atom-optics Lévy kicked rotor." Physical review. E vol. 100,6 (2019): 060201. doi: https://doi.org/10.1103/PhysRevE.100.060201
Paul S, Sarkar S, Vishwakarma C, Mangaonkar J, Santhanam MS, Rapol U. Nonmonotonic diffusion rates in an atom-optics Lévy kicked rotor. Phys Rev E. 2019 Dec;100(6):060201. doi: 10.1103/PhysRevE.100.060201. PMID: 31962514.
Copy Download .nbib Format: NLM
Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.

Mayo Clinic proceedings

Koster MJ, Kourelis T, Reichard KK, Kermani TA, Beck DB, Cardona DO, Samec MJ, Mangaonkar AA, Begna KH, Hook CC, Oliveira JL, Nasr SH, Tiong BK, Patnaik MM, Burke MM, Michet CJ, Warrington KJ.
PMID: 34489099
Mayo Clin Proc. 2021 Oct;96(10):2653-2659. doi: 10.1016/j.mayocp.2021.06.006. Epub 2021 Sep 03.

The objective of this study is to describe the clinical features and outcomes of patients with the newly defined vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. Nine men with somatic mutations in the UBA1 gene were identified; the...

Cite
Koster MJ, Kourelis T, Reichard KK, et al. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series. Mayo Clin Proc. 2021;96(10):2653-2659doi: 10.1016/j.mayocp.2021.06.006.
Koster, M. J., Kourelis, T., Reichard, K. K., Kermani, T. A., Beck, D. B., Cardona, D. O., Samec, M. J., Mangaonkar, A. A., Begna, K. H., Hook, C. C., Oliveira, J. L., Nasr, S. H., Tiong, B. K., Patnaik, M. M., Burke, M. M., Michet, C. J., & Warrington, K. J. (2021). Clinical Heterogeneity of the VEXAS Syndrome: A Case Series. Mayo Clinic proceedings, 96(10), 2653-2659. https://doi.org/10.1016/j.mayocp.2021.06.006
Koster, Matthew J, et al. "Clinical Heterogeneity of the VEXAS Syndrome: A Case Series." Mayo Clinic proceedings vol. 96,10 (2021): 2653-2659. doi: https://doi.org/10.1016/j.mayocp.2021.06.006
Koster MJ, Kourelis T, Reichard KK, Kermani TA, Beck DB, Cardona DO, Samec MJ, Mangaonkar AA, Begna KH, Hook CC, Oliveira JL, Nasr SH, Tiong BK, Patnaik MM, Burke MM, Michet CJ, Warrington KJ. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series. Mayo Clin Proc. 2021 Oct;96(10):2653-2659. doi: 10.1016/j.mayocp.2021.06.006. Epub 2021 Sep 03. PMID: 34489099.
Copy Download .nbib Format: NLM
Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths.

Blood cancer journal

Mangaonkar AA, Ferrer A, Vairo FPE, Hammel CW, Prochnow C, Gangat N, Hogan WJ, Litzow MR, Peters SG, Scott JP, Utz JP, Baqir M, Carmona-Porquera EM, Kalra S, Sekiguchi H, Khan SP, Simonetto DA, Klee EW, Kamath PS, Roden AC, Joshi AY, Kennedy CC, Wylam ME, Patnaik MM.
PMID: 34686653
Blood Cancer J. 2021 Oct 22;11(10):170. doi: 10.1038/s41408-021-00564-7.

No abstract available.

Cite
Mangaonkar AA, Ferrer A, Vairo FPE, et al. Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths. Blood Cancer J. 2021;11(10):170doi: 10.1038/s41408-021-00564-7.
Mangaonkar, A. A., Ferrer, A., Vairo, F. P. E., Hammel, C. W., Prochnow, C., Gangat, N., Hogan, W. J., Litzow, M. R., Peters, S. G., Scott, J. P., Utz, J. P., Baqir, M., Carmona-Porquera, E. M., Kalra, S., Sekiguchi, H., Khan, S. P., Simonetto, D. A., Klee, E. W., Kamath, P. S., Roden, A. C., Joshi, A. Y., Kennedy, C. C., Wylam, M. E., & Patnaik, M. M. (2021). Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths. Blood cancer journal, 11(10), 170. https://doi.org/10.1038/s41408-021-00564-7
Mangaonkar, Abhishek A, et al. "Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths." Blood cancer journal vol. 11,10 (2021): 170. doi: https://doi.org/10.1038/s41408-021-00564-7
Mangaonkar AA, Ferrer A, Vairo FPE, Hammel CW, Prochnow C, Gangat N, Hogan WJ, Litzow MR, Peters SG, Scott JP, Utz JP, Baqir M, Carmona-Porquera EM, Kalra S, Sekiguchi H, Khan SP, Simonetto DA, Klee EW, Kamath PS, Roden AC, Joshi AY, Kennedy CC, Wylam ME, Patnaik MM. Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths. Blood Cancer J. 2021 Oct 22;11(10):170. doi: 10.1038/s41408-021-00564-7. PMID: 34686653; PMCID: PMC8536738.
Copy Download .nbib Format: NLM
Advances in chronic myelomonocytic leukemia and future prospects: Lessons learned from precision genomics.

Advances in cell and gene therapy

Mangaonkar AA, Patnaik MM.
PMID: 31559392
Adv Cell Gene Ther. 2019 Apr;2(2). doi: 10.1002/acg2.48. Epub 2019 Jan 16.

In the latest World Health Organization classification of myeloid neoplasms, chronic myelomonocytic leukemia (CMML) exists as a separate entity under the category of myelodysplastic/myeloproliferative (MDS/MPN) overlap syndromes. Outcomes remain uniformly poor with a median overall survival of ~2 years...

Cite
Mangaonkar AA, Patnaik MM. Advances in chronic myelomonocytic leukemia and future prospects: Lessons learned from precision genomics. Adv Cell Gene Ther. 2019;2(2)doi: 10.1002/acg2.48.
Mangaonkar, A. A., & Patnaik, M. M. (2019). Advances in chronic myelomonocytic leukemia and future prospects: Lessons learned from precision genomics. Advances in cell and gene therapy, 2(2), . https://doi.org/10.1002/acg2.48
Mangaonkar, Abhishek A, and Patnaik, Mrinal M. "Advances in chronic myelomonocytic leukemia and future prospects: Lessons learned from precision genomics." Advances in cell and gene therapy vol. 2,2 (2019). doi: https://doi.org/10.1002/acg2.48
Mangaonkar AA, Patnaik MM. Advances in chronic myelomonocytic leukemia and future prospects: Lessons learned from precision genomics. Adv Cell Gene Ther. 2019 Apr;2(2). doi: 10.1002/acg2.48. Epub 2019 Jan 16. PMID: 31559392; PMCID: PMC6763205.
Copy Download .nbib Format: NLM
ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.

Hematology reports

Jillella AP, Arellano ML, Heffner LT, Gaddh M, Langston AA, Khoury HJ, Mangaonkar A, Kota VK.
PMID: 31871613
Hematol Rep. 2019 Dec 04;11(4):8395. doi: 10.4081/hr.2019.8395. eCollection 2019 Nov 29.

No abstract available.

Cite
Jillella AP, Arellano ML, Heffner LT, et al. ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematol Rep. 2019;11(4):8395doi: 10.4081/hr.2019.8395.
Jillella, A. P., Arellano, M. L., Heffner, L. T., Gaddh, M., Langston, A. A., Khoury, H. J., Mangaonkar, A., & Kota, V. K. (2019). ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematology reports, 11(4), 8395. https://doi.org/10.4081/hr.2019.8395
Jillella, Anand P, et al. "ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation." Hematology reports vol. 11,4 (2019): 8395. doi: https://doi.org/10.4081/hr.2019.8395
Jillella AP, Arellano ML, Heffner LT, Gaddh M, Langston AA, Khoury HJ, Mangaonkar A, Kota VK. ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematol Rep. 2019 Dec 04;11(4):8395. doi: 10.4081/hr.2019.8395. eCollection 2019 Nov 29. PMID: 31871613; PMCID: PMC6902306.
Copy Download .nbib Format: NLM
Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia.

The Journal of community and supportive oncology

Mangaonkar A, Xu H, Mohsin J, Mansour J, Chintalapally R, Keen R, Mondal AK, DeRemer D, Clemmons AB, Clark SM, Shah A, Jillela A, Kolhe R, Kota V.
PMID: 26955659
J Community Support Oncol. 2016 Feb;14(2):66-71. doi: 10.12788/jcso.0231.

BACKGROUND: Complete remission (CR) in acute myeloid leukemia (AML) is defined as having ≤5% leukemic blast cells in the bone marrow and return of normal hematopoiesis after the first induction cycle. There is a subset of patients, however, who...

Cite
Mangaonkar A, Xu H, Mohsin J, et al. Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia. J Community Support Oncol. 2016;14(2):66-71doi: 10.12788/jcso.0231.
Mangaonkar, A., Xu, H., Mohsin, J., Mansour, J., Chintalapally, R., Keen, R., Mondal, A. K., DeRemer, D., Clemmons, A. B., Clark, S. M., Shah, A., Jillela, A., Kolhe, R., & Kota, V. (2016). Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia. The Journal of community and supportive oncology, 14(2), 66-71. https://doi.org/10.12788/jcso.0231
Mangaonkar, Abhishek, et al. "Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia." The Journal of community and supportive oncology vol. 14,2 (2016): 66-71. doi: https://doi.org/10.12788/jcso.0231
Mangaonkar A, Xu H, Mohsin J, Mansour J, Chintalapally R, Keen R, Mondal AK, DeRemer D, Clemmons AB, Clark SM, Shah A, Jillela A, Kolhe R, Kota V. Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia. J Community Support Oncol. 2016 Feb;14(2):66-71. doi: 10.12788/jcso.0231. PMID: 26955659.
Copy Download .nbib Format: NLM
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms.

Blood advances

Alkhateeb HB, Nanaa A, Viswanatha DS, Foran JM, Badar T, Sproat L, He R, Nguyen P, Jevremovic D, Salama ME, Greipp PT, Gangat N, Tefferi A, Litzow MR, Mangaonkar AA, Shah MV, Patnaik MM, Al-Kali A.
PMID: 34644397
Blood Adv. 2021 Oct 13; doi: 10.1182/bloodadvances.2021005738. Epub 2021 Oct 13.

DDX41 mutations (germline and somatic) are associated with late onset myelodysplastic syndromes/acute myeloid leukemia (MDS/AML). Myeloid neoplasms (MN) with germline predisposition was identified as a distinct category in the 2016 WHO classification revision, including MN with germline DDX41 mutation....

Cite
Alkhateeb HB, Nanaa A, Viswanatha DS, et al. Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms. Blood Adv. 2021;doi: 10.1182/bloodadvances.2021005738.
Alkhateeb, H. B., Nanaa, A., Viswanatha, D. S., Foran, J. M., Badar, T., Sproat, L., He, R., Nguyen, P., Jevremovic, D., Salama, M. E., Greipp, P. T., Gangat, N., Tefferi, A., Litzow, M. R., Mangaonkar, A. A., Shah, M. V., Patnaik, M. M., & Al-Kali, A. (2021). Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms. Blood advances, . https://doi.org/10.1182/bloodadvances.2021005738
Alkhateeb, Hassan B, et al. "Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms." Blood advances vol. (2021). doi: https://doi.org/10.1182/bloodadvances.2021005738
Alkhateeb HB, Nanaa A, Viswanatha DS, Foran JM, Badar T, Sproat L, He R, Nguyen P, Jevremovic D, Salama ME, Greipp PT, Gangat N, Tefferi A, Litzow MR, Mangaonkar AA, Shah MV, Patnaik MM, Al-Kali A. Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms. Blood Adv. 2021 Oct 13; doi: 10.1182/bloodadvances.2021005738. Epub 2021 Oct 13. PMID: 34644397.
Copy Download .nbib Format: NLM
Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population.

Hepatology communications

Rattan P, Penrice DD, Ahn JC, Ferrer A, Patnaik M, Shah VH, Kamath PS, Mangaonkar AA, Simonetto DA.
PMID: 34558851
Hepatol Commun. 2021 Aug 28; doi: 10.1002/hep4.1803. Epub 2021 Aug 28.

Physiologic aging leads to attrition of telomeres and replicative senescence. An acceleration of this process has been hypothesized in the progression of chronic liver disease. We sought to examine the association of telomere length (TL) with liver disease and...

Cite
Rattan P, Penrice DD, Ahn JC, et al. Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population. Hepatol Commun. 2021;doi: 10.1002/hep4.1803.
Rattan, P., Penrice, D. D., Ahn, J. C., Ferrer, A., Patnaik, M., Shah, V. H., Kamath, P. S., Mangaonkar, A. A., & Simonetto, D. A. (2021). Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population. Hepatology communications, . https://doi.org/10.1002/hep4.1803
Rattan, Puru, et al. "Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population." Hepatology communications vol. (2021). doi: https://doi.org/10.1002/hep4.1803
Rattan P, Penrice DD, Ahn JC, Ferrer A, Patnaik M, Shah VH, Kamath PS, Mangaonkar AA, Simonetto DA. Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population. Hepatol Commun. 2021 Aug 28; doi: 10.1002/hep4.1803. Epub 2021 Aug 28. PMID: 34558851.
Copy Download .nbib Format: NLM
Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.

Mayo Clinic proceedings

Koster MJ, Kourelis T, Reichard KK, Kermani TA, Beck DB, Cardona DO, Samec MJ, Mangaonkar AA, Begna KH, Hook CC, Oliveira JL, Nasr SH, Tiong BK, Patnaik MM, Burke MM, Michet CJ, Warrington KJ.
PMID: 34489099
Mayo Clin Proc. 2021 Oct;96(10):2653-2659. doi: 10.1016/j.mayocp.2021.06.006. Epub 2021 Sep 03.

The objective of this study is to describe the clinical features and outcomes of patients with the newly defined vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. Nine men with somatic mutations in the UBA1 gene were identified; the...

Cite
Koster MJ, Kourelis T, Reichard KK, et al. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series. Mayo Clin Proc. 2021;96(10):2653-2659doi: 10.1016/j.mayocp.2021.06.006.
Koster, M. J., Kourelis, T., Reichard, K. K., Kermani, T. A., Beck, D. B., Cardona, D. O., Samec, M. J., Mangaonkar, A. A., Begna, K. H., Hook, C. C., Oliveira, J. L., Nasr, S. H., Tiong, B. K., Patnaik, M. M., Burke, M. M., Michet, C. J., & Warrington, K. J. (2021). Clinical Heterogeneity of the VEXAS Syndrome: A Case Series. Mayo Clinic proceedings, 96(10), 2653-2659. https://doi.org/10.1016/j.mayocp.2021.06.006
Koster, Matthew J, et al. "Clinical Heterogeneity of the VEXAS Syndrome: A Case Series." Mayo Clinic proceedings vol. 96,10 (2021): 2653-2659. doi: https://doi.org/10.1016/j.mayocp.2021.06.006
Koster MJ, Kourelis T, Reichard KK, Kermani TA, Beck DB, Cardona DO, Samec MJ, Mangaonkar AA, Begna KH, Hook CC, Oliveira JL, Nasr SH, Tiong BK, Patnaik MM, Burke MM, Michet CJ, Warrington KJ. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series. Mayo Clin Proc. 2021 Oct;96(10):2653-2659. doi: 10.1016/j.mayocp.2021.06.006. Epub 2021 Sep 03. PMID: 34489099.
Copy Download .nbib Format: NLM
Recurrent Parotid Carcinosarcoma in an Asymptomatic Patient.

Journal of investigative medicine high impact case reports

Mansour J, Mangaonkar A, Kota V.
PMID: 27847832
J Investig Med High Impact Case Rep. 2016 Nov 04;4(4):2324709616676590. doi: 10.1177/2324709616676590. eCollection 2016.

In this article, we present the case of a 52-year-old male with a history of parotid carcinosarcoma with initial diagnosis being 18 months prior. Initial treatment included a combination of gamma knife surgery coupled with high dosage chemotherapy and...

Cite
Mansour J, Mangaonkar A, Kota V. Recurrent Parotid Carcinosarcoma in an Asymptomatic Patient. J Investig Med High Impact Case Rep. 2016;4(4):2324709616676590doi: 10.1177/2324709616676590.
Mansour, J., Mangaonkar, A., & Kota, V. (2016). Recurrent Parotid Carcinosarcoma in an Asymptomatic Patient. Journal of investigative medicine high impact case reports, 4(4), 2324709616676590. https://doi.org/10.1177/2324709616676590
Mansour, Joshua, et al. "Recurrent Parotid Carcinosarcoma in an Asymptomatic Patient." Journal of investigative medicine high impact case reports vol. 4,4 (2016): 2324709616676590. doi: https://doi.org/10.1177/2324709616676590
Mansour J, Mangaonkar A, Kota V. Recurrent Parotid Carcinosarcoma in an Asymptomatic Patient. J Investig Med High Impact Case Rep. 2016 Nov 04;4(4):2324709616676590. doi: 10.1177/2324709616676590. eCollection 2016. PMID: 27847832; PMCID: PMC5098685.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 22 entries